Medications for Hematopoietic Subsyndrome Of Acute Radiation Syndrome

4 results

  • leukine - sargramostim injection, powder, lyophilized, for solution

    (Sargramostim)
    Partner Therapeutics, Inc.
    Leukine is a leukocyte growth factor used to shorten neutrophil recovery after AML chemotherapy in adults 55+, mobilize stem cells for transplant, accelerate myeloid reconstitution after bone marrow or progenitor cell transplantation, treat delayed neutrophil recovery or graft failure, and increase survival after myelosuppressive radiation exposure.
    Medication Details
    Drug Interactions

  • neulasta - pegfilgrastim

    (Pegfilgrastim)
    Amgen, Inc
    Neulasta reduces infection risk from febrile neutropenia in adults and pediatric patients with non-myeloid malignancies undergoing myelosuppressive chemotherapy. Also increases survival in patients acutely exposed to myelosuppressive radiation doses. Not indicated for stem cell transplantation progenitor cell mobilization.
    Medication Details
    Drug Interactions

  • neupogen - filgrastim injection, solution

    (Filgrastim)
    Amgen, Inc
    NEUPOGEN is a leukocyte growth factor used to reduce infection risk and neutropenia in cancer patients on chemotherapy or bone marrow transplant, treat AML-related neutropenia, mobilize stem cells for collection, manage severe chronic neutropenia, and improve survival after myelosuppressive radiation exposure.
    Medication Details
    Drug Interactions

  • nplate - romiplostim injection, powder, lyophilized, for solution

    (Romiplostim)
    Amgen, Inc
    Nplate treats thrombocytopenia in adults and pediatric patients (age 1+) with immune thrombocytopenia (ITP) who had insufficient response to corticosteroids, immunoglobulins, or splenectomy. Also indicated to increase survival in adults and pediatric patients acutely exposed to myelosuppressive radiation doses (Hematopoietic Syndrome of Acute Radiation Syndrome).
    Medication Details
    Drug Interactions